Voluven - 2007 FDA approvals

Drug: Voluven
Indication: Significant blood loss 
Company: Fresenius Kabi
Approval Date: December 27, 2007

Scoop: Voluven, an intravenous solution that prevents and treats a dangerous loss of blood volume, a condition that sometimes occurs during and after surgery. Voluven contains a synthetic starch that does not dissolve in water. It is made by linking individual starch molecules together and combining them with a salt solution, similar to the salt concentration typically found in blood. Voluven expands the volume of blood plasma and draws fluid into capillaries.